You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
New research suggests Ebola virus may appear in survivor sperm samples some nine months after disease onset, though sexual transmission appears relatively rare.
Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.
The study demonstrated the efficacy of using the Oxford Nanopore MinIon and a bespoke computational pipeline to perform metagenomics testing of viral infections in patients.
The test previously received Emergency Use Authorization from the US Food and Drug Administration and is now eligible for WHO procurement.
A National Institutes of Health team demonstrated EBOV RNA can be found in semen using strategies approved for finding the virus in blood.
At The Atlantic, Ed Yong reports on the MinION's use to track Ebola in Africa.
The developers of a web-based tool originally designed to track flu virus evolution have released versions of their software that track changes in other troublesome viruses.
The device uses silver nanoparticles functionalized with antibodies and requires no electricity, cold storage, specialized reagents, or other infrastructure.
Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.
The study found BioFire FilmArray assays preformed comparably to RT-qPCR tests developed by the CDC, but were faster and easier to use.
US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.
In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.
Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.
Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.